Pursuant to National Instrument 62-103, The Early Warning System
and Related Take-Over Bids and Insider Reporting Issues, Ms.
Hamutal Yitzhak and Mr. Uriel Kesler (together, the
“
Filers”) were each required to file an early
warning report in relation to their respective change in holdings
of the 104,196,220 outstanding common shares (each, a
“
Share”) in the capital of Else Nutrition Holdings
Inc. (the “
Issuer”) by more than 2% from the date
of their previously filed early warning reports.
- The change in
the security holdings of Ms. Yitzhak and Mr. Kesler is a result of
general dilution to shareholders due to the number of additional
Shares issued by the Issuer from treasury since the date of their
respective prior reports and is not a result of a
disposition of Shares by either Filer.
Ms. Hamutal Yitzhak’s Early Warning Report
Effective December 12, 2021, Ms. Yitzhak ceased
to exercise voting control or direction (the “Deemed
Disposition”) over an aggregate of 599,995 Shares,
pursuant to the voting support agreements more particularly
described in Ms. Yitzhak’s early warning report dated December 14,
2020. Since the date of the prior report, Ms. Yitzhak’s holdings in
the Share class decreased from approximately 16.20% (as of December
14, 2020) to approximately 13.74% of the current outstanding
Shares. This represents an overall decrease of approximately 2.46%,
on a partially-diluted basis, assuming the exercise of 488,184
stock options to acquire Shares (each, an
“Option”) which are beneficially held by Ms.
Yitzhak and are exercisable today or within 60 days.
Immediately prior to the Deemed Disposition, Ms.
Yitzhak held beneficial ownership, direction or control over an
aggregate of 14,430,012 Shares and 481,944 Options, representing
approximately 13.84%, on a non-diluted basis, and approximately
14.31%, on a partially-diluted basis, of the current outstanding
Shares, assuming the deemed exercise of the 481,944 Options.
Immediately after the Deemed Disposition, Ms.
Yitzhak held or is deemed to hold beneficial ownership, direction
or control over, an aggregate of 13,830,017 Shares and 488,194
Options, representing approximately 13.27%, on a non-diluted basis,
and approximately 13.74%, on a partially-diluted basis, of the
current outstanding Shares, assuming the deemed exercise of 488,194
Options. The holdings include the vested portion of the 75,000
Options granted to Ms. Yitzhak on November 12, 2021, as more
particularly described in the Issuer's press release dated
November 12, 2021, and the balance of the 599,995 Shares
over which Ms. Yitzhak continues to exercise voting control or
direction in accordance with the voting support agreements.
Mr. Uriel Kesler’s Early Warning Report
Effective December 12, 2021, Mr. Kesler was
deemed to have acquired voting control and direction over an
additional 6,250 Shares as a result of the vesting of a portion of
the 75,000 Options granted to Mr. Kesler on November 12, 2021 (the
“Vested Options”). Since the date of Mr. Kesler’s
prior early warning report dated June 13, 2019, Mr. Kesler’s
holdings in the Share class decreased from approximately 19.71% (as
of June 13, 2019) to approximately 13.15% of the current
outstanding Shares. This represents an overall decrease of
approximately 6.54%, on a partially-diluted basis, assuming the
exercise of 474,306 Options which are beneficially held by Mr.
Kesler and are exercisable today or within 60 days.
Immediately prior to the Vested Options, Mr.
Kesler held beneficial ownership, direction or control over an
aggregate of 13,230,012 Shares and 481,944 Options, representing
approximately 12.70%, on a non-diluted basis, and approximately
13.15%, on a partially-diluted basis, of the current outstanding
Shares, assuming the deemed exercise of the 481,944 Options.
Immediately after the Vested Options, Mr. Kesler
held or is deemed to hold beneficial ownership, direction or
control over, an aggregate of 13,230,012 Shares and 488,194
Options, representing approximately 12.70%, on a non-diluted basis,
and approximately 13.16%, on a partially-diluted basis, of the
current outstanding Shares, assuming the deemed exercise of 488,194
Options.
Immediately after the Vested Options, Mr. Kesler
held or is deemed to hold beneficial ownership, direction or
control over, an aggregate of 13,230,012 Shares and 474,306
Options, representing approximately 12.70%, on a non-diluted basis,
and approximately 13.15%, on a partially-diluted basis, of the
current outstanding Shares, assuming the deemed exercise of 474,306
Options.
The Shares and Options (together, the
“Securities”) are held by the Filers for
investment purposes. While each respective Filer currently has no
plans or intentions with respect to the Issuer's Securities,
depending on market conditions, general economic and industry
conditions, trading prices of the Issuer's Shares, the Issuer's
business, financial condition and prospects and/or other relevant
factors, the Filers may develop such plans or intentions in the
future and, at such time, may from time to time acquire additional
Securities, dispose of some or all of the existing or additional
Securities or may continue to hold the Securities of the
Issuer.
A copy of the early warning report in respect of
the foregoing matters will be available on the Issuer's profile on
SEDAR at www.sedar.com.
The head office of the Issuer is located at 6 Hanechoshet St.,
Tel Aviv, Israel, 6971070.
FOR MORE INFORMATION:
For further information or to receive a copy of
the early warning report, please contact Ms. Yitzhak,
Chief Executive Officer and director of the Issuer, at
hamutaly@elsenutrition.com or +972(0)52-447-9931 or Oziel Law
at (416) 900-0882 x 307 (Attn: Andy Andrei) or refer to the
Issuer's profile on the System for Electronic Document Analysis and
Review (www.sedar.com).
Else Nutrition (TSXV:BABY)
過去 株価チャート
から 11 2024 まで 12 2024
Else Nutrition (TSXV:BABY)
過去 株価チャート
から 12 2023 まで 12 2024